European stocks finished Monday mixed as Asia-Pacific markets broadly rose, with investor attention focused on the latest developments in the U.S.-Iran war.
Shares of Novartis dropped as much as 3.6% early Monday after it said an experimental drug failed to reduce the risk of cardiovascular events in a late-stage trial compared to placebo.
While the med… [+1277 chars]
While the med… [+1277 chars]